JP2023530936A5 - - Google Patents

Info

Publication number
JP2023530936A5
JP2023530936A5 JP2022577084A JP2022577084A JP2023530936A5 JP 2023530936 A5 JP2023530936 A5 JP 2023530936A5 JP 2022577084 A JP2022577084 A JP 2022577084A JP 2022577084 A JP2022577084 A JP 2022577084A JP 2023530936 A5 JP2023530936 A5 JP 2023530936A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
compound
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022577084A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023530936A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/037578 external-priority patent/WO2021257670A1/en
Publication of JP2023530936A publication Critical patent/JP2023530936A/ja
Publication of JP2023530936A5 publication Critical patent/JP2023530936A5/ja
Pending legal-status Critical Current

Links

JP2022577084A 2020-06-17 2021-06-16 真菌感染症を処置するための化合物および方法 Pending JP2023530936A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063040450P 2020-06-17 2020-06-17
US63/040,450 2020-06-17
PCT/US2021/037578 WO2021257670A1 (en) 2020-06-17 2021-06-16 Compounds and methods for treating fungal infections

Publications (2)

Publication Number Publication Date
JP2023530936A JP2023530936A (ja) 2023-07-20
JP2023530936A5 true JP2023530936A5 (https=) 2024-06-21

Family

ID=79268375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022577084A Pending JP2023530936A (ja) 2020-06-17 2021-06-16 真菌感染症を処置するための化合物および方法

Country Status (12)

Country Link
US (1) US20230233586A1 (https=)
EP (1) EP4167998A4 (https=)
JP (1) JP2023530936A (https=)
KR (1) KR20230024375A (https=)
CN (1) CN115884775A (https=)
AU (1) AU2021293911B2 (https=)
BR (1) BR112022024988A2 (https=)
CA (1) CA3187268A1 (https=)
IL (1) IL299057A (https=)
MX (1) MX2022016179A (https=)
TW (1) TWI888580B (https=)
WO (1) WO2021257670A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022010804A (es) 2020-03-04 2023-01-16 Amplyx Pharmaceuticals Inc Uso de compuestos en el tratamiento de infecciones fungicas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
EP2636409A1 (en) * 2010-11-05 2013-09-11 Eisai R&D Management Co., Ltd. Combined pharmaceutical composition as antifungal agent
WO2020047510A1 (en) * 2018-08-31 2020-03-05 Amplyx Pharmaceuticals, Inc. Compounds and methods for treating fungal infections
US11819503B2 (en) * 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
MX2022010804A (es) * 2020-03-04 2023-01-16 Amplyx Pharmaceuticals Inc Uso de compuestos en el tratamiento de infecciones fungicas.

Similar Documents

Publication Publication Date Title
JP2023516648A5 (https=)
CN107249584A (zh) 用于抑制真菌感染的组合物和方法
US12521406B2 (en) Use of compounds in the treatment of fungal infections
JP2023030113A5 (https=)
JP2023530936A5 (https=)
AU2024227501A1 (en) Antifungal agents with enhanced activity in acidic pH
Harari Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients
JP2008540506A (ja) 抗真菌剤およびカルベオール、オイゲノール、チモール、ボルネオール、カルバクロール、ならびにアルファ−およびベータ−イオノンから選択される活性物質を含んでなる製薬組成物
Van Cutsem In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Odds Itraconazole—a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses
AU2021293911B2 (en) Compounds and methods for treating fungal infections
Kramer et al. The fluconazole era: Management of hematogenously disseminated candidiasis in the nonneutropenic patient
Sharma et al. A short review on liquisolid technology in anti-fungal drugs: https://doi. org/10.54037/WJPS. 2022.100116
RU2824066C1 (ru) Соединения и способы для лечения грибковых инфекций
TWI910099B (zh) 用於治療或預防肺囊蟲屬肺炎之三萜類抗真菌劑
Raj Antifungal Drugs
EA047126B1 (ru) Противогрибковое средство для лечения или профилактики инфекции вульвовагинального кандидоза
AS Antifungal therapy
Harvengt Drugs Recently Released In Belgium: Fluconazole-Xamoterol fumarate
HK40030410A (en) Antifungal agents with enhanced activity in acidic ph
Carrillo Muñoz et al. Sertaconazole, a useful antifungal agent for the topical treatment of superficial candidiasis